Sbi-Securities-Co

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-02
Total Holdings
4,132
Total Value
2997716131
Accession Number
0001851815-25-000004
Form Type
13F-HR
Manager Name
Sbi-Securities-Co
Data Enrichment
81% identified
3,363 identified769 unidentified

Holdings

4,132 positions • $3.0B total value
Manager:
Search and click to pin securities to the top
BARNWELL INDUSTRIES INC
Shares:1
Value:$2
% of Portfolio:0.0% ($2/$3.0B)
iPower Inc.
Shares:4
Value:$2
% of Portfolio:0.0% ($2/$3.0B)
Pyxis Oncology, Inc.
Shares:2
Value:$2
% of Portfolio:0.0% ($2/$3.0B)
TPI COMPOSITES, INC
Shares:3
Value:$2
% of Portfolio:0.0% ($2/$3.0B)
Nuvation Bio Inc.
Shares:1
Value:$2
% of Portfolio:0.0% ($2/$3.0B)
G2181K113
Shares:14
Value:$2
% of Portfolio:0.0% ($2/$3.0B)
Perspective Therapeutics, Inc.
Shares:1
Value:$2
% of Portfolio:0.0% ($2/$3.0B)
HYDROFARM HOLDINGS GROUP, INC.
Shares:1
Value:$2
% of Portfolio:0.0% ($2/$3.0B)
90177C200
Shares:6
Value:$2
% of Portfolio:0.0% ($2/$3.0B)
RYVYL Inc.
Shares:2
Value:$2
% of Portfolio:0.0% ($2/$3.0B)
Aqua Metals, Inc.
Shares:1
Value:$2
% of Portfolio:0.0% ($2/$3.0B)
SUTRO BIOPHARMA, INC.
Shares:3
Value:$2
% of Portfolio:0.0% ($2/$3.0B)
DATA I/O CORP
Shares:1
Value:$2
% of Portfolio:0.0% ($2/$3.0B)
Accelerate Diagnostics, Inc
Shares:3
Value:$2
% of Portfolio:0.0% ($2/$3.0B)
DSS, INC.
Shares:2
Value:$2
% of Portfolio:0.0% ($2/$3.0B)
DIH HOLDING US, INC.
Shares:10
Value:$2
% of Portfolio:0.0% ($2/$3.0B)
Adaptimmune Therapeutics PLC
Shares:10
Value:$2
% of Portfolio:0.0% ($2/$3.0B)
Verrica Pharmaceuticals Inc.
Shares:4
Value:$2
% of Portfolio:0.0% ($2/$3.0B)
UNITED STATES ANTIMONY CORP
Shares:1
Value:$2
% of Portfolio:0.0% ($2/$3.0B)
Airsculpt Technologies, Inc.
Shares:1
Value:$2
% of Portfolio:0.0% ($2/$3.0B)